Short Interest in Precipio, Inc. (NASDAQ:PRPO) Drops By 15.6%

Precipio, Inc. (NASDAQ:PRPO) saw a large drop in short interest in December. As of December 31st, there was short interest totalling 2,700 shares, a drop of 15.6% from the December 15th total of 3,200 shares. Based on an average trading volume of 7,100 shares, the days-to-cover ratio is presently 0.4 days. Currently, 0.2% of the company’s stock are short sold.

Precipio Stock Up 0.8 %

NASDAQ PRPO traded up $0.05 during trading hours on Thursday, reaching $6.15. 4,212 shares of the company’s stock traded hands, compared to its average volume of 8,931. Precipio has a 52-week low of $4.31 and a 52-week high of $7.30. The company has a debt-to-equity ratio of 0.02, a current ratio of 0.73 and a quick ratio of 0.60. The firm has a 50-day simple moving average of $5.86 and a 200 day simple moving average of $5.93. The firm has a market cap of $9.10 million, a PE ratio of -3.36 and a beta of 1.41.

About Precipio

Precipio, Inc, a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels.